SCHEMBL19081905

SCHEMBL19081905

c1ccc(-c2c3ccccc3c(-c3cccc(-c4ccc5oc6ccc7c8cc9ccccc9cc8sc7c6c5c4)c3)c3ccccc23)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 4/20 0.36
PLA2G4A P47712 4/20 0.36
PLA2G10 O15496 1/20 0.36
ESR1 P03372 6/20 0.34
ESR2 Q92731 5/20 0.34
LIMK1 P53667 4/20 0.33
LIMK2 P53671 1/20 0.32
CYP1A1 P04798 2/20 0.31
CYP1A2 P05177 1/20 0.31
FYN P06241 1/20 0.31
MAPK3 P27361 1/20 0.31
AHR P35869 1/20 0.31
PAX8 Q06710 1/20 0.31
ABCG2 Q9UNQ0 1/20 0.31
CYP1B1 Q16678 1/20 0.31
PRKDC P78527 1/20 0.31
CASP3 P42574 1/20 0.30
SENP7 Q9BQF6 1/20 0.30
SENP6 Q9GZR1 1/20 0.30
CCNE2 O96020 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19076673 0.91 PLA2G2A (0.35) PLA2G2APLA2G4APLA2G10ESR1ESR2
SCHEMBL19076744 0.89 PLA2G2A (0.33) PLA2G2APLA2G4APLA2G10LIMK1LIMK2
SCHEMBL19076868 0.87 PGR (0.36) PLA2G2APLA2G4APLA2G10ESR1ESR2
SCHEMBL18268656 0.87 PGR (0.33) PLA2G2APLA2G4AESR1ESR2LIMK1
SCHEMBL17932250 0.86 PLA2G2A (0.36) PLA2G2APLA2G4APLA2G10LIMK1CYP1A1
SCHEMBL19076851 0.85 TDP1 (0.34) ESR1ESR2CYP1A1CYP1A2ABCG2
SCHEMBL19082243 0.85 ESR1 (0.36) ESR1ESR2LIMK1CYP1A1CYP1A2
SCHEMBL19076710 0.85 TDP1 (0.32) PLA2G2APLA2G4APLA2G10LIMK1LIMK2
SCHEMBL19082226 0.85 ESR1 (0.39) ESR1ESR2LIMK1CYP1A1CYP1A2
SCHEMBL18842988 0.84 PLA2G2A (0.34) PLA2G2APLA2G4APLA2G10LIMK1LIMK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 PLA2G2A 4330/4885PLA2G4A 4338/4885PLA2G10 4054/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 PLA2G2A 4330/4885PLA2G4A 4338/4885PLA2G10 4054/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.